EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deciphering the Interplay Among Inflammatory Bowel Disease, Gut Microbiota, and Inflammatory Biomarkers in the Risk of Colorectal Cancer

Chenyu Luo iD, Bowen Tian iD, Yueyang Zhou iD, Jiahui Luo iD, Qing Shang iD, Si Yu iD, Min Dai iD, Yue Li iD, Hongda Chen iD

Mediators of Inflammation · 2025

DOI: 10.1155/mi/4967641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2025. Verfasst von Chenyu Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medic…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colorectal Neoplasms, Gastrointestinal Microbiome, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with inflammatory bowel disease (IBD) have an elevated colorectal cancer (CRC) risk, though the etiology remains unclear. This study aimed to elucidate the interplay among IBD, gut microbiota (GM), inflammatory biomarkers, and CRC risk.

Methods

First, we employed cohort analysis using the UK Biobank (UKB), linkage disequilibrium score regression (LDSC), and Mendelian randomization (MR) analyses to investigate the association between IBD and CRC. Second, inflammatory biomarkers’ indirect effect was assessed using mediation analysis. Third, the causal effects of IBD on GM and GM on inflammatory biomarkers were evaluated using MR. Finally, we constructed a disease severity biomarker score and evaluated its CRC risk stratification performance.

Results

Among 441,321 participants, IBD was associated with a 1.78‐fold (95% confidence interval (CI): 1.45–2.18) increased risk of CRC. While LDSC and MR analyses showed no genetic correlation between IBD and CRC, mediation analyses revealed that C‐reactive protein (CRP) and neutrophil‐to‐lymphocyte ratio (NLR) significantly mediated 10.41% and 9.97% of the IBD–CRC association, respectively. IBD increased the GM abundance of Rikenellaceae RC9 gut group , and decreased Lactobacillaceae and Ruminococcus 2 , which in turn affected CRP, neutrophils, and lymphocytes. Notably, IBD decreased the abundance of Ruminococcus 2 after Bonferroni correction ( β = −9.463, p = 0.0002). A disease severity biomarker score comprising of CRP, platelets, platelet‐to‐lymphocyte ratio (PLR), NLR, hemoglobin (Hgb), and albumin was constructed. IBD patients with the highest scores had a 3.07‐fold (95% CI: 1.35–7.00) higher CRC risk compared to those with the lowest scores.

Conclusions

IBD alters the microbial abundance of Rikenellaceae RC9 gut group , Lactobacillaceae , and Ruminococcus 2 , thereby, influencing inflammatory biomarkers including CRP, neutrophils, and lymphocytes, which mediate the increased risk of CRC in IBD patients. The constructed biomarker score enables individualized CRC risk stratification in IBD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesColorectal NeoplasmsGastrointestinal MicrobiomeBiomarkersHumansCohort StudiesUK BiobankRiskLinkage DisequilibriumMendelian Randomization AnalysisPatient AcuityMaleFemaleMiddle AgedEducational StatusSocioeconomic FactorsRuminococcusLactobacillalesBacteria

Stichwörter der Autor:innen

colorectal cancergut microbiotainflammatory biomarkersinflammatory bowel disease

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Uni…
  • Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.

ORCID-Profile: Chenyu Luo, Bowen Tian, Yueyang Zhou, Jiahui Luo, Qing Shang, Si Yu, Min Dai, Yue Li, Hongda Chen

Förderung

  • Chinese Academy of Medical Sciences
  • National Natural Science Foundation of China
  • Beijing Nova Program

Zitieren

APA

Luo, C., Tian, B., Zhou, Y., Luo, J., Shang, Q., Yu, S., Dai, M., Li, Y., & Chen, H. (2025). Deciphering the Interplay Among Inflammatory Bowel Disease, Gut Microbiota, and Inflammatory Biomarkers in the Risk of Colorectal Cancer. Mediators of Inflammation. https://doi.org/10.1155/mi/4967641

Vancouver

Luo C, Tian B, Zhou Y, Luo J, Shang Q, Yu S, et al. Deciphering the Interplay Among Inflammatory Bowel Disease, Gut Microbiota, and Inflammatory Biomarkers in the Risk of Colorectal Cancer. Mediators of Inflammation. 2025. doi:10.1155/mi/4967641

BibTeX
@article{Luo2025,
  author = {Luo, Chenyu and Tian, Bowen and Zhou, Yueyang and Luo, Jiahui and Shang, Qing and Yu, Si and Dai, Min and Li, Yue and Chen, Hongda},
  title = {Deciphering the Interplay Among Inflammatory Bowel Disease, Gut Microbiota, and Inflammatory Biomarkers in the Risk of Colorectal Cancer},
  journal = {Mediators of Inflammation},
  year = {2025},
  doi = {10.1155/mi/4967641}
}
Kostenlos starten →